Pharmaceutical Drug Delivery Market

Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital) - Global Forecast to 2023

Report Code: MD 3871 Mar, 2019, by marketsandmarkets.com

[289 Pages Report] The global pharmaceutical drug delivery market is projected to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period. Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches.

The topical drug delivery market is expected to grow at the highest CAGR during the forecast period.

Based on route of administration, the pharmaceutical drug delivery market is segmented into oral, pulmonary, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. The topical drug delivery market is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the wide range of advantages associated with this route of administration, including convenience and ease of use, right dosage to the right place, painless and noninvasive delivery, superior spreadability, and enhanced patient compliance.

Growing demand for biosimilars to drive the market for conventional injection devices

Based on type, the injectable drug delivery technology market is segmented into conventional injection devices, self-injection devices, and other devices. The conventional injection devices segment accounted for the largest market share in 2018. The large share of this segment is due to the increasing prevalence of chronic diseases (particularly cancer and diabetes) and CVD, growing demand for biosimilar products, and low cost of devices and manufacturing.

Hospitals were estimated to be the largest facility of use of pharmaceutical drug delivery in 2018

On the basis of facility of use, the pharmaceutical drug delivery market is segmented into hospitals, ambulatory surgical centers (ASCs)/clinics, diagnostic centers, home care settings, and other facilities of use. In 2018, the hospitals segment accounted for the largest share of the pharmaceutical drug delivery market. This can be attributed to the significant number of inpatient and outpatient visits to hospitals and the requirement of large volumes of drugs and their respective delivery devices to cater to the demand of the large patient pool.

In 2018, North America accounted for the largest share of the market

Geographically, North America accounted for the largest share of 39.8% of the market in 2018, followed by Europe. The large share of the North American market is due to factors such as growth in biologics in the pharmaceuticals market; the rising prevalence of chronic diseases such as cancer, respiratory allergies, and diabetes; increasing patient compliance to innovative drug delivery technologies; and the presence of a large number of prominent players in this region.

Key Market Players

The global pharmaceutical drug delivery market is highly fragmented owing to the presence of several large and small players. Johnson & Johnson, Inc. (US), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (US), Bayer AG (Germany), Pfizer, Inc. (US), Novartis AG (Switzerland), 3M Company (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc, (UK), Sanofi (France), and Antares Pharma, Inc. (US) are some of the leading players operating in the market.
Johnson & Johnson, Inc is one of the prominent players in the pharmaceutical drug delivery market. The company offers a robust product portfolio and has a strong geographical presence in this market. The company has 125 manufacturing facilities all across the globe. J&J primarily focuses on products related to human health and well-being. Innovation is an integral part of the company. The firm is committed to improving human therapeutic medicines through continuous investment in R&D.

Novartis AG is another leading player in the pharmaceutical drug delivery market. The company’s strong brand recognition and extensive product portfolio in this market are its key strengths. To maintain its leading position in the market, the company adopts organic as well as inorganic growth strategies such as acquisitions and expansions.

Recent Developments

  • In 2018, Johnson & Johnson, Inc signed an agreement with the Oklahoma Health Care Authority (OHCA), (US). Under this agreement, OHCA aimed to improve care among patients with schizophrenia and to cut down the expenses for medical services. The agreement is focused on enabling the use of INVEGA SUSTENNA (paliperidone palmitate) and INVEGA TRINZA (paliperidone palmitate) in the treatment of adults with schizophrenia.
  • In 2018, Johnson & Johnson, Inc collaborated with the Jenner Institute at the University of Oxford to develop and manufacture a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
  • In 2018, Novartis signed an agreement with Gan & Lee (China) to commercialize and supply biosimilar versions of insulins (glargine, lispro and aspart, the three top insulin medicines by sales), used in patients with type 1 and type 2 diabetes.

Key Questions Addressed by the Report

  • Where will all these developments take the industry in the mid-to-long term?
  • What are the recent trends affecting the pharmaceutical drug delivery market?
  • Who are the key players in the market and how intense is the competition?
  • What are the application areas of pharmaceutical drug delivery?
  • What type of drug delivery technology are companies exploring?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 28)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 31)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Market Data Validation and Triangulation
    2.3 Assumptions for the Study

3 Executive Summary (Page No. - 40)

4 Premium Insights (Page No. - 44)
    4.1 Drug Delivery Technology: Market Overview
    4.2 Drug Delivery Technology Market, By Route of Administration, 2018 Vs. 2023 (USD Billion)
    4.3 Drug Delivery Technology Market, By Facility of Use, 2018–2023 (USD Billion)
    4.4 Drug Delivery Technology Market Share, By Application and Region, 2018
    4.5 Drug Delivery Technology Market: Geographic Growth Opportunities

5 Market Overview (Page No. - 48)
    5.1 Introduction
    5.2 Market Dynamics
    5.3 Drivers
           5.3.1 Rising Prevalence of Chronic Diseases
           5.3.2 Growth in the Biologics Market
           5.3.3 Technological Advancements and New Product Launches
    5.4 Restraints
           5.4.1 Risk of Needlestick Injuries
    5.5 Opportunities
           5.5.1 Self-Administration and Home Care
           5.5.2 Rising Demand for Biosimilars
    5.6 Challenges
           5.6.1 Pricing Pressure

6 Drug Delivery Technology Market, By Route of Administration (Page No. - 53)
    6.1 Introduction
    6.2 Oral Drug Delivery
           6.2.1 Solid Oral Drugs
                    6.2.1.1 Tablets
                               6.2.1.1.1 Development of Mini-Tablets is A Key Trend in This Market Segment.
                    6.2.1.2 Capsules
                               6.2.1.2.1 Easy Absorption of Drugs and Decreased Irritation in the Gi Tract are Driving the Use of

Capsules
                    6.2.1.3 Powders
                               6.2.1.3.1 Powders are Taken By Patients Who are Unable to Swallow Oral Dosage Forms
                    6.2.1.4 Pills
                               6.2.1.4.1 Rising Incidence of Target Ailments Will Propel the Growth of the Pills Market
           6.2.2 Liquid Oral Drugs
                    6.2.2.1 Syrups
                               6.2.2.1.1 Liquid Syrups Can Be Easily Administered to Patients With Swallowing Difficulties
                    6.2.2.2 Solutions
                               6.2.2.2.1 Solutions are Generally Preferred By Geriatric and Pediatric Patients
           6.2.3 Semi-Solid Oral Drugs
                    6.2.3.1 Gels
                               6.2.3.1.1 Gels are Used for Controlled Drug Release
                    6.2.3.2 Emulsions
                               6.2.3.2.1 Microemulsions Offer Protection Against Oxidation and Enzymatic Hydrolysis
                    6.2.3.3 Elixirs
                               6.2.3.3.1 Elixirs are Hydraulic in Nature and Contain Sweet and Flavored Substances
    6.3 Injectable Drug Delivery
           6.3.1 Conventional Injection Devices
                    6.3.1.1 By Material
                               6.3.1.1.1 Glass
                                             6.3.1.1.1.1 Glass Syringes are Considered to Be One of the Most Durable and Safe Materials to Store Biologic Drugs
                               6.3.1.1.2 Plastic
                                             6.3.1.1.2.1 Plastic Syringes are Reasonably Priced as Compared to Their Glass Counterparts
                    6.3.1.2 By Product
                               6.3.1.2.1 Fillable Syringes
                                             6.3.1.2.1.1 Ease of Use and Variable Dosing Formulations of Fillable Syringes are the Major Factors Driving Market Growth
                               6.3.1.2.2 Prefilled Syringes
                                             6.3.1.2.2.1 Prefilled Syringes Offer Improved Dose Accuracy and Increased Patient Convenience and Safety
                    6.3.1.3 By Usability
                               6.3.1.3.1 Reusable Syringes
                                             6.3.1.3.1.1 Reusable Syringes are Easy to Dismantle and Clean
                               6.3.1.3.2 Disposable Syringes
                                             6.3.1.3.2.1 Disposable Syringes are Widely Used in Medical Practices Due to Their Low Cost and Convenience
           6.3.2 Self-Injection Devices
                    6.3.2.1 Needle-Free Injectors
                               6.3.2.1.1 Needle-Free Injectors Enable Fast Drug Delivery and Show Better Reproducibility as Compared to Invasive Drug Delivery Systems
                    6.3.2.2 Autoinjectors
                               6.3.2.2.1 Autoinjectors Provide Improved Patient Satisfaction as Compared to Manual Injections
                    6.3.2.3 Pen Injectors
                               6.3.2.3.1 Pen Injectors are Generally Used When Medications Have to Be Administered More Than Once A Week
                    6.3.2.4 Wearable Injectors
                               6.3.2.4.1 Increasing Adoption of Home Infusion Therapy and Rising Focus on Cost-Curtailment in Healthcare are Supporting Market Growth
           6.3.3 Other Injector Devices
    6.4 Topical Drug Delivery
           6.4.1 Liquid Formulations
                    6.4.1.1 Solutions
                               6.4.1.1.1 Solutions Accounted for A Larger Share of the Topical Drug Delivery Technology Market for Liquid Formulations in 2018
                    6.4.1.2 Suspensions
                               6.4.1.2.1 Factors Such as Higher Rate of Bioavailability and Controlled Onset of Action to Support the Growth of the Topical Suspensions Market in the Coming Years
           6.4.2 Semi-Solid Formulations
                    6.4.2.1 Creams
                               6.4.2.1.1 Creams are Either Water-In-Oil Or Oil-In-Water Emulsions
                    6.4.2.2 Gels
                               6.4.2.2.1 Factors Such as Faster Drug Release and Greater Patient Acceptability to Drive the Market for Topical Gels
                    6.4.2.3 Ointments
                               6.4.2.3.1 Ointments are Widely Used in Analgesic Indications
                    6.4.2.4 Pastes
                               6.4.2.4.1 Topical Pastes are Widely Used for the Treatment and Prevention of Skin Irritation
                    6.4.2.5 Lotions
                               6.4.2.5.1 Easy Administration of Lotions to Drive Their Demand Among End Users
           6.4.3 Solid Formulations
                    6.4.3.1 Suppositories
                               6.4.3.1.1 Suppositories Require A Suitable Base That Ensures the Compatibility and Stability of the Drug
                    6.4.3.2 Powders
                               6.4.3.2.1 Powders Have A Very Fine Particle Size That Covers A Large Surface Area Per Unit Weight
           6.4.4 Transdermal Products
                    6.4.4.1 Transdermal Patches
                               6.4.4.1.1 Transdermal Patches Prevent the Premature Metabolization of the Drug Through the Liver
                    6.4.4.2 Transdermal Gels
                               6.4.4.2.1 Transdermal Gels Help in the Faster Release of Drugs on the Target Site
    6.5 Ocular Drug Delivery
           6.5.1 Liquid Formulations
                    6.5.1.1 Eye Drops
                               6.5.1.1.1 Rising Prevalence of Cataracts and Other Eye Diseases is Driving Market Growth
                    6.5.1.2 Liquid Sprays
                               6.5.1.2.1 Liquid Sprays Have Helped in Overcoming Drawbacks Associated With Traditional Eye Drops
           6.5.2 Semi-Solid Formulations
                    6.5.2.1 Gels
                               6.5.2.1.1 High Viscosity of Drugs, Prolonged Drug Release, and Ease of Drug Administration are Factors Contributing to Market Growth
                    6.5.2.2 Eye Ointments
                               6.5.2.2.1 Eye Ointments are Safe to Use, and Help in Improving Ocular Contact Time With the Drug
           6.5.3 Ocular Devices
                    6.5.3.1 Drug-Coated Contact Lenses
                               6.5.3.1.1 Better Eyesight Offered By Lenses & High Compliance to Drive the Market for Drug-Coated Contact Lenses
                    6.5.3.2 Ocular Inserts
                               6.5.3.2.1 Ocular Inserts Help in the Sustained Release of Drugs in the Eye
    6.6 Pulmonary Drug Delivery
           6.6.1 Metered-Dose Inhalers
                    6.6.1.1 These Inhalers Overcome the Problem of Poor Coordination Between Inhaler Actuation and Patient Breath
           6.6.2 Dry Powder Inhalers
                    6.6.2.1 Dpi Drug Formulations are Chemically More Stable Than Their Counterparts Are
           6.6.3 Nebulizers
                    6.6.3.1 Jet Nebulizers
                               6.6.3.1.1 Jet Nebulizers Account for the Largest Share of the Nebulizers Market
                    6.6.3.2 Ultrasonic Nebulizers
                               6.6.3.2.1 Ultrasonic Nebulizers are Easy to Use and Comfortable to Handle
                    6.6.3.3 Soft Mist Nebulizers
                               6.6.3.3.1 Soft Mist Nebulizers are Preferred for the Treatment of Severe Copd
    6.7 Nasal Drug Delivery
           6.7.1 Nasal Drops
                    6.7.1.1 Nasal Drops are Considered More Efficient Than Nasal Sprays
           6.7.2 Nasal Sprays
                    6.7.2.1 Nasal Sprays Help in Relieving Nasal Congestion, Runny Nose, Itchy Nose, and Sneezing
           6.7.3 Nasal Powders
                    6.7.3.1 Absence of Preservatives & Superior Stability of Formulations are Some of the Advantages Associated With Nasal Powders
           6.7.4 Nasal Gels
                    6.7.4.1 Nasal Gels Provide Long-Lasting Relief From Dry Nasal Passages and Also Reduce Irritation Caused By Using Soothing Excipients
    6.8 Transmucosal Drug Delivery
           6.8.1 Oral Formulations
                    6.8.1.1 Buccal Drug Delivery
                               6.8.1.1.1 Buccal Drug Delivery System is Suitable for Local and Systematic Therapies
                    6.8.1.2 Sublingual Drug Delivery
                               6.8.1.2.1 the Rate of Drug Absorption Through the Sublingual Route is 3–10 Times Higher Than the Oral Route
           6.8.2 Other Transmucosal Drug Delivery Technologies
                    6.8.2.1 Rectal Transmucosal Drug Delivery
                               6.8.2.1.1 the Rectal Route of Drug Delivery Rapidly Absorbs Drugs That are Aqueous in Nature
                    6.8.2.2 Vaginal Transmucosal Drug Delivery
                               6.8.2.2.1 the Permeability of the Drug is High Through the Vaginal Route of Administration
    6.9 Implantable Drug Delivery
           6.9.1 Active Implantable Drug Delivery
                    6.9.1.1 Active Implantable Devices are Used for Diagnostic Monitoring, Body Fluids Transportation, and Ionized Radiation
           6.9.2 Passive Implantable Drug Delivery
                    6.9.2.1 Passive Implants Primarily Include Joint Replacements, Heart Valves, Aneurysm Clips, Coronary Stents, and Breast Implants

7 Drug Delivery Technology Market, By Patient Care Setting (Page No. - 123)
    7.1 Introduction
    7.2 Hospitals
           7.2.1 Hospitals Will Continue to Dominate the Drug Delivery Technology Market During the Forecast Period
    7.3 Ambulatory Surgery Centers/Clinics
           7.3.1 Increasing Preference for ASCS has Resulted in A Significant Rise in Demand for Drug Delivery Technologies
    7.4 Home Care Settings
           7.4.1 Home Care Settings to Register the Highest Growth Rate During the Forecast Period
    7.5 Diagnostic Centers
           7.5.1 Rising Prevalence of Chronic Diseases to Support Market Growth
    7.6 Other Facilities of Use

8 Drug Delivery Technology Market, By Application (Page No. - 129)
    8.1 Introduction
    8.2 Infectious Diseases
           8.2.1 High Burden of Infectious Diseases Across the Globe to Drive Market Growth
    8.3 Cancer
           8.3.1 Cancer Forms A Key Therapeutic Application Segment for Drug Delivery Technologies
    8.4 Cardiovascular Diseases
           8.4.1 Increasing Prevalence of Cvds is Driving the Growth of the Drug Delivery Technology Market
    8.5 Diabetes
           8.5.1 Emergence of New Technologies is Supporting Market Growth
    8.6 Respiratory Diseases
           8.6.1 High Prevalence of Asthma & Copd to Drive the Adoption of Drug Delivery Technologies
    8.7 Central Nervous System Disorders
           8.7.1 Oral and Injectable Drug Delivery Systems are Widely Used in the Treatment of Cns Disorders
    8.8 Autoimmune Diseases
           8.8.1 Autoimmune Diseases Segment to Register the Highest Growth in the Forecast Period
    8.9 Other Applications
           8.9.1 Ophthalmic Disorders
           8.9.2 Endocrine Disorders

9 Drug Delivery Technology Market, By Region (Page No. - 139)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 Rising Prevalence of Chronic Diseases and Strong Presence of Key Market Players – Major Factors Driving Market Growth in the US
           9.2.2 Canada
                    9.2.2.1 Government Support for Research and the Rising Prevalence of Chronic Diseases are the Major Factors Driving Market Growth in Canada
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Growing Focus of Pharmaceutical Companies on the Development of Various Drug Delivery Products is Expected to Drive Market Growth in Germany
           9.3.2 France
                    9.3.2.1 High Insurance Coverage Coupled With the Increasing Prevalence of Chronic Diseases to Drive Market Growth in France
           9.3.3 UK
                    9.3.3.1 Increasing Incidence and Prevalence of Chronic and Infectious Diseases to Drive the Demand for Drug Delivery Technologies in the UK
           9.3.4 Rest of Europe
    9.4 Asia Pacific
           9.4.1 Japan
                    9.4.1.1 Favorable Government Initiatives and Increasing Geriatric Population Will Drive Market Growth in Japan
           9.4.2 China
                    9.4.2.1 China Had the Largest Diabetic Population in the World in 2017
           9.4.3 India
                    9.4.3.1 Favorable Initiatives and High Disease Incidence Will Drive Market Growth in India
           9.4.4 Rest of Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 202)
     10.1 Overview
     10.2 Market Player Ranking, 2017
     10.3 Competitive Scenario
     10.4 Competitive Leadership Mapping (2017)
             10.4.1 Vendor Inclusion Criteria
             10.4.2 Visionary Leaders
             10.4.3 Innovators
             10.4.4 Dynamic Differentiators
             10.4.5 Emerging Companies
     10.5 Competitive Leadership Mapping for Start-Ups (2017)
             10.5.1 Progressive Companies
             10.5.2 Starting Blocks
             10.5.3 Responsive Companies
             10.5.4 Dynamic Companies

11 Company Profile (Page No. - 210)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     11.1 Johnson & Johnson Services, Inc.
     11.2 Novartis AG
     11.3 F. Hoffmann-La Roche Ltd.
     11.4 Pfizer, Inc.
     11.5 Bayer AG
     11.6 Antares Pharma, Inc.
     11.7 Becton, Dickinson and Company
     11.8 GlaxoSmithKline PLC
     11.9 3M
     11.10 Merck & Co., Inc.
     11.11 Sanofi

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 282)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (261 Tables)

Table 1 Indicative List of Biologics Approved By the FDA (2017)
Table 2 Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 3 Oral Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 4 Oral Drug Delivery Technology Market, By Dosage Form, 2016–2023 (USD Billion)
Table 5 Oral Drug Delivery Technology Market for Solid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 6 Oral Drug Delivery Technology Market for Solid Drugs, By Region, 2016–2023 (USD Billion)
Table 7 Capsules Market, By Region, 2016–2023 (USD Billion)
Table 8 Powders Market, By Region, 2016–2023 (USD Billion)
Table 9 Pills Market, By Region, 2016–2023 (USD Billion)
Table 10 Oral Drug Delivery Technology Market for Liquid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 11 Oral Drug Delivery Technology Market for Liquid Drugs, By Region, 2016–2023 (USD Billion)
Table 12 Oral Syrups Market, By Region, 2016–2023 (USD Billion)
Table 13 Oral Solutions Market, By Region, 2016–2023 (USD Billion)
Table 14 Oral Drug Delivery Technology Market for Semi-Solid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 15 Oral Drug Delivery Technology Market for Semi-Solid Drugs, By Region, 2014–2021 (USD Billion)
Table 16 Oral Gels Market, By Region, 2016–2023 (USD Billion)
Table 17 Oral Emulsions Market, By Region, 2016–2023 (USD Billion)
Table 18 Elixirs Market, By Region, 2016–2023 (USD Million)
Table 19 Injectable Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 20 Injectable Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 21 Injectable Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 22 Injectable Drug Delivery Technology Market for Conventional Devices, By Region, 2016–2023 (USD Billion)
Table 23 Injectable Drug Delivery Technology Market for Conventional Devices, By Material, 2016–2023 (USD Billion)
Table 24 Glass Syringes Market, By Region, 2016–2023 (USD Billion)
Table 25 Plastic Syringes Market, By Region, 2016–2023 (USD Billion)
Table 26 Injectable Drug Delivery Technology Market for Conventional Devices, By Product, 2016–2023 (USD Billion)
Table 27 Fillable Syringes Market, By Region, 2016–2023 (USD Billion)
Table 28 Prefilled Syringes Market, By Region, 2016–2023 (USD Billion)
Table 29 Injectable Drug Delivery Technology Market for Conventional Devices, By Usability, 2016–2023 (USD Billion)
Table 30 Reusable Syringes Market, By Region, 2016–2023 (USD Billion)
Table 31 Disposable Syringes Market, By Region, 2016–2023 (USD Billion)
Table 32 Injectable Drug Delivery Technology Market for Self-Injection Devices, By Type, 2016–2023 (USD Billion)
Table 33 Injectable Drug Delivery Technology Market for Self-Injection Devices, By Region, 2016–2023 (USD Billion)
Table 34 Needle-Free Injectors Market, By Region, 2016–2023 (USD Billion)
Table 35 Autoinjectors Market, By Region, 2016–2023 (USD Billion)
Table 36 Commercially Available Key Pen Injectors
Table 37 Pen Injectors Market, By Region, 2016–2023 (USD Billion)
Table 38 Wearable Injectors Market, By Region, 2016–2023 (USD Million)
Table 39 Other Injector Devices Market, By Region, 2016–2023 (USD Billion)
Table 40 Topical Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 41 Topical Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 42 Topical Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 43 Topical Drug Delivery Technology Market for Liquid Formulations, By Region, 2016–2023 (USD Billion)
Table 44 Topical Solutions Market, By Region, 2016–2023 (USD Billion)
Table 45 Topical Suspensions Market, By Region, 2016–2023 (USD Billion)
Table 46 Topical Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 47 Topical Drug Delivery Technology Market for Semi-Solid Formulations, By Region, 2016–2023 (USD Billion)
Table 48 Topical Creams Market, By Region, 2016–2023 (USD Billion)
Table 49 Topical Gels Market, By Region, 2016–2023 (USD Million)
Table 50 Topical Ointments Market, By Region, 2016–2023 (USD Billion)
Table 51 Topical Pastes Market, By Region, 2016–2023 (USD Million)
Table 52 Topical Lotions Market, By Region, 2016–2023 (USD Billion)
Table 53 Topical Drug Delivery Technology Market for Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 54 Topical Drug Delivery Technology Market for Solid Formulations, By Region, 2016–2023 (USD Million)
Table 55 Topical Suppositories Market, By Region, 2016–2023 (USD Million)
Table 56 Topical Powders Market, By Region, 2016–2023 (USD Billion)
Table 57 Topical Drug Delivery Technology Market for Transdermal Products, By Type, 2016–2023 (USD Billion)
Table 58 Topical Drug Delivery Technology Market for Transdermal Products, By Region, 2016–2023 (USD Billion)
Table 59 Transdermal Patches Market, By Region, 2016–2023 (USD Million)
Table 60 Transdermal Gels Market, By Region, 2016–2023 (USD Million)
Table 61 Ocular Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 62 Ocular Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 63 Ocular Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 64 Ocular Drug Delivery Technology Market for Liquid Formulations, By Region, 2016–2023 (USD Billion)
Table 65 Commercially Available Eye Drops
Table 66 Eye Drops Market, By Region, 2016–2023 (USD Billion)
Table 67 Liquid Sprays Market, By Region, 2016–2023 (USD Billion)
Table 68 Ocular Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 69 Ocular Drug Delivery Technology Market for Semi-Solid Formulations, By Region, 2016–2023 (USD Million)
Table 70 Ocular Gels Market, By Region, 2016–2023 (USD Billion)
Table 71 Eye Ointments Market, By Region, 2016–2023 (USD Million)
Table 72 Ocular Drug Delivery Technology Market for Ocular Devices, By Type, 2016–2023 (USD Million)
Table 73 Ocular Drug Delivery Technology Market for Ocular Devices, By Region, 2016–2023 (USD Million)
Table 74 Drug-Coated Contact Lenses Market, By Region, 2016–2023 (USD Million)
Table 75 Ocular Inserts Market, By Region, 2016–2023 (USD Billion)
Table 76 Pulmonary Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 77 Pulmonary Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 78 Pulmonary Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 79 Pulmonary Drug Delivery Technology Market for Metered-Dose Inhalers, By Region, 2016–2023 (USD Billion)
Table 80 Pulmonary Drug Delivery Technology Market for Dry Powder Inhalers, By Region, 2016–2023 (USD Billion)
Table 81 Pulmonary Drug Delivery Technology Market for Nebulizers, By Type, 2016–2023 (USD Billion)
Table 82 Pulmonary Drug Delivery Technology Market for Nebulizers, By Region, 2016–2023 (USD Billion)
Table 83 Jet Nebulizers Market, By Region, 2016–2023 (USD Million)
Table 84 Ultrasonic Nebulizers Market, By Region, 2016–2023 (USD Million)
Table 85 Soft Mist Nebulizers Market, By Region, 2016–2023 (USD Million)
Table 86 Nasal Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 87 Nasal Drug Delivery Technology Market, By Dosage Form, 2016–2023 (USD Billion)
Table 88 Nasal Drops Market, By Region, 2016–2023 (USD Billion)
Table 89 Nasal Sprays Market, By Region, 2016–2023 (USD Billion)
Table 90 Nasal Powders Market, By Region, 2016–2023 (USD Million)
Table 91 Nasal Gels Market, By Region, 2016–2023 (USD Million)
Table 92 Transmucosal Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 93 Transmucosal Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 94 Transmucosal Drug Delivery Technology Market for Oral Formulations, By Type, 2016–2023 (USD Billion)
Table 95 Transmucosal Drug Delivery Technology Market for Oral Formulations, By Region, 2016–2023 (USD Billion)
Table 96 Buccal Drug Delivery Technology Market, By Region, 2016–2023 (USD Billion)
Table 97 Sublingual Drug Delivery Technology Market, By Region, 2016–2023 (USD Billion)
Table 98 Transmucosal Drug Delivery Technology Market for Other Formulations, By Type, 2016–2023 (USD Million)
Table 99 Transmucosal Drug Delivery Technology Market for Other Formulations, By Region, 2016–2023 (USD Million)
Table 100 Rectal Transmucosal Drug Delivery Technology Market, By Region, 2016–2023 (USD Million)
Table 101 Vaginal Transmucosal Drug Delivery Technology Market, By Region, 2016–2023 (USD Million)
Table 102 Implantable Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 103 Implantable Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 104 Active Implantable Drug Delivery Technology Market, By Region, 2016–2023 (USD Million)
Table 105 Passive Implantable Drug Delivery Technology Market, By Region, 2016–2023 (USD Billion)
Table 106 Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 107 Drug Delivery Technology Market for Hospitals, By Region, 2016–2023 (USD Billion)
Table 108 Drug Delivery Technology Market for Ambulatory Surgery Centers/Clinics, By Region, 2016–2023 (USD Billion)
Table 109 Drug Delivery Technology Market for Home Care Settings, By Region, 2016–2023 (USD Billion)
Table 110 Drug Delivery Technology Market for Diagnostic Centers, By Region, 2016–2023 (USD Billion)
Table 111 Drug Delivery Technology Market for Other Facilities of Use, By Region, 2016–2023 (USD Billion)
Table 112 Drug Delivery Technology Market, By Application, 2016–2023 (USD Billion)
Table 113 Drug Delivery Technology Market for Infectious Diseases, By Region, 2016–2023 (USD Billion)
Table 114 Drug Delivery Technology Market for Cancer, By Region, 2016–2023 (USD Billion)
Table 115 Drug Delivery Technology Market for Cardiovascular Diseases, By Region, 2016–2023 (USD Billion)
Table 116 Drug Delivery Technology Market for Diabetes, By Region, 2016–2023 (USD Billion)
Table 117 Drug Delivery Technology Market for Respiratory Diseases, By Region, 2016–2023 (USD Billion)
Table 118 Drug Delivery Technology Market for Central Nervous System Disorders, By Region, 2016–2023 (USD Billion)
Table 119 Drug Delivery Technology Market for Autoimmune Diseases, By Region, 2016–2023 (USD Billion)
Table 120 Drug Delivery Technology Market for Other Applications, By Region, 2016–2023 (USD Billion)
Table 121 Drug Delivery Technology Market, By Region, 2016–2023 (USD Billion)
Table 122 North America: Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 123 North America: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 124 North America: Oral Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 125 North America: Oral Drug Delivery Technology Market for Solid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 126 North America: Oral Drug Delivery Technology Market for Liquid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 127 North America: Oral Drug Delivery Technology Market for Semi-Solid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 128 North America: Injectable Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 129 North America: Injectable Drug Delivery Technology Market for Conventional Devices, By Material, 2016–2023 (USD Billion)
Table 130 North America: Injectable Drug Delivery Technology Market for Conventional Devices, By Product, 2016–2023 (USD Billion)
Table 131 North America: Injectable Drug Delivery Technology Market for Conventional Devices, By Usability, 2016–2023 (USD Billion)
Table 132 North America: Injectable Drug Delivery Technology Market for Self-Injection Devices, By Type, 2016–2023 (USD Billion)
Table 133 North America: Ocular Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 134 North America: Ocular Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 135 North America: Ocular Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 136 North America: Ocular Drug Delivery Technology Market for Ocular Devices, By Type, 2016–2023 (USD Million)
Table 137 North America: Nasal Drug Delivery Technology Market, By Dosage Form, 2016–2023 (USD Million)
Table 138 North America: Topical Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 139 North America: Topical Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 140 North America: Topical Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 141 North America: Topical Drug Delivery Technology Market for Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 142 North America: Topical Drug Delivery Technology Market for Transdermal Products, By Type, 2016–2023 (USD Million)
Table 143 North America: Implantable Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 144 North America: Transmucosal Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 145 North America: Transmucosal Drug Delivery Technology Market for Oral Formulations, By Type, 2016–2023 (USD Billion)
Table 146 North America: Transmucosal Drug Delivery Technology Market for Other Formulations, By Type, 2016–2023 (USD Million)
Table 147 North America: Pulmonary Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 148 North America: Pulmonary Drug Delivery Technology Market for Nebulizers, By Type, 2016–2023 (USD Million)
Table 149 North America: Drug Delivery Technology Market, By Application, 2016–2023 (USD Billion)
Table 150 North America: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 151 US: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 152 US: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 153 Canada: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 154 Canada: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 155 Europe: Drug Delivery Technology Market, By Country, 2016–2023 (USD Billion)
Table 156 Europe: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 157 Europe: Oral Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 158 Europe: Oral Drug Delivery Technology Market for Solid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 159 Europe: Oral Drug Delivery Technology Market for Liquid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 160 Europe: Oral Drug Delivery Technology Market for Semi-Solid Drugs, By Dosage Form, 2016–2023 (USD Billion)
Table 161 Europe: Injectable Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 162 Europe: Injectable Drug Delivery Technology Market for Conventional Devices, By Material, 2016–2023 (USD Billion)
Table 163 Europe: Injectable Drug Delivery Technology Market for Conventional Devices, By Product, 2016–2023 (USD Billion)
Table 164 Europe: Injectable Drug Delivery Technology Market for Conventional Devices, By Usability, 2016–2023 (USD Billion)
Table 165 Europe: Injectable Drug Delivery Technology Market for Self-Injection Devices, By Type, 2016–2023 (USD Billion)
Table 166 Europe: Ocular Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 167 Europe: Ocular Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 168 Europe: Ocular Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 169 Europe: Ocular Drug Delivery Technology Market for Ocular Devices, By Type, 2016–2023 (USD Million)
Table 170 Europe: Nasal Drug Delivery Technology Market, By Dosage Form, 2016–2023 (USD Million)
Table 171 Europe: Topical Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 172 Europe: Topical Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 173 Europe: Topical Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 174 Europe: Topical Drug Delivery Technology Market for Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 175 Europe: Topical Drug Delivery Technology Market for Transdermal Products, By Type, 2016–2023 (USD Million)
Table 176 Europe: Implantable Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 177 Europe: Transmucosal Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 178 Europe: Transmucosal Drug Delivery Technology Market for Oral Formulations, By Type, 2016–2023 (USD Billion)
Table 179 Europe: Transmucosal Drug Delivery Technology Market for Other Formulations, By Type, 2016–2023 (USD Million)
Table 180 Europe: Pulmonary Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 181 Europe: Pulmonary Drug Delivery Technology Market for Nebulizers, By Type, 2016–2023 (USD Million)
Table 182 Europe: Drug Delivery Technology Market, By Application, 2016–2023 (USD Billion)
Table 183 Europe: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 184 Germany: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 185 Germany: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 186 France: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 187 France: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 188 UK: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 189 UK: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 190 RoE: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 191 RoE: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 192 APAC: Drug Delivery Technology Market, By Country, 2016-2023 (USD Billion)
Table 193 APAC: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 194 APAC: Oral Drug Delivery Technology Market, By Dosage Form, 2016-2023 (USD Billion)
Table 195 APAC: Oral Drug Delivery Technology Market for Solid Drugs, By Dosage Form, 2016-2023 (USD Billion)
Table 196 APAC: Oral Drug Delivery Technology Market for Liquid Drugs, By Dosage Form, 2016-2023 (USD Billion)
Table 197 APAC: Oral Drug Delivery Technology Market for Semi-Solid Drugs, By Dosage Form, 2016-2023 (USD Billion)
Table 198 APAC: Injectable Drug Delivery Technology Market, By Type, 2016-2023 (USD Billion)
Table 199 APAC: Injectable Drug Delivery Technology Market for Conventional Devices, By Material, 2016–2023 (USD Billion)
Table 200 APAC: Injectable Drug Delivery Technology Market for Conventional Devices, By Product, 2016–2023 (USD Billion)
Table 201 APAC: Injectable Drug Delivery Technology Market for Conventional Devices, By Usability, 2016–2023 (USD Billion)
Table 202 APAC: Injectable Drug Delivery Technology Market for Self-Injection Devices, By Type, 2016–2023 (USD Billion)
Table 203 APAC: Ocular Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 204 APAC: Ocular Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 205 APAC: Ocular Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 206 APAC: Ocular Drug Delivery Technology Market for Ocular Devices, By Type, 2016–2023 (USD Million)
Table 207 APAC: Nasal Drug Delivery Technology Market, By Dosage Form, 2016–2023 (USD Million)
Table 208 APAC: Topical Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 209 APAC: Topical Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 210 APAC: Topical Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 211 APAC: Topical Drug Delivery Technology Market for Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 212 APAC: Topical Drug Delivery Technology Market for Transdermal Products, 2016–2023 (USD Million)
Table 213 APAC: Implantable Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 214 APAC: Transmucosal Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 215 APAC: Transmucosal Drug Delivery Technology Market for Oral Formulations, By Type, 2016–2023 (USD Billion)
Table 216 APAC: Transmucosal Drug Delivery Technology Market for Other Formulations, By Type, 2016–2023 (USD Million)
Table 217 APAC: Pulmonary Drug Delivery Technology Market, By Type, 2016–2023 (USD Billion)
Table 218 APAC: Pulmonary Drug Delivery Technology Market for Nebulizers,  By Type, 2016–2023 (USD Million)
Table 219 APAC: Drug Delivery Technology Market, By Application, 2016–2023 (USD Billion)
Table 220 APAC: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 221 Japan: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 222 Japan: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 223 China: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 224 China: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 225 India: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 226 India: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 227 RoAPAC: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Million)
Table 228 RoA: Drug Delivery Technology Market, By End User, 2016–2023 (USD Billion)
Table 229 RoW: Drug Delivery Technology Market, By Route of Administration, 2016–2023 (USD Billion)
Table 230 RoW: Oral Drug Delivery Technology Market, By Dosage Form, 2016-2023 (USD Billion)
Table 231 RoW: Oral Drug Delivery Technology Market for Solid Drugs, By Dosage Form, 2016-2023 (USD Billion)
Table 232 RoW: Oral Drug Delivery Technology Market for Liquid Drugs, By Dosage Form, 2016-2023 (USD Billion)
Table 233 RoW: Oral Drug Delivery Technology Market for Semi-Solid Drugs, By Dosage Form, 2016-2023 (USD Million)
Table 234 RoW: Injectable Drug Delivery Technology Market, By Type, 2016-2023 (USD Million)
Table 235 RoW: Injectable Drug Delivery Technology Market for Conventional Devices, By Material, 2016–2023 (USD Billion)
Table 236 RoW: Injectable Drug Delivery Technology Market for Conventional Devices, By Product, 2016–2023 (USD Billion)
Table 237 RoW: Injectable Drug Delivery Technology Market for Conventional Devices, 2016–2023 (USD Billion)
Table 238 RoW: Injectable Drug Delivery Technology Market for Self-Injection Devices Market, By Type, 2016–2023 (USD Million)
Table 239 RoW: Ocular Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 240 RoW: Ocular Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Billion)
Table 241 RoW: Ocular Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 242 RoW: Ocular Drug Delivery Technology Market for Ocular Devices, By Type, 2016–2023 (USD Million)
Table 243 RoW: Nasal Drug Delivery Technology Market, By Dosage Form, 2016–2023 (USD Million)
Table 244 RoW: Topical Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 245 RoW: Topical Drug Delivery Technology Market for Liquid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 246 RoW: Topical Drug Delivery Technology Market for Semi-Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 247 RoW: Topical Drug Delivery Technology Market for Solid Formulations, By Dosage Form, 2016–2023 (USD Million)
Table 248 RoW: Topical Drug Delivery Technology Market for Transdermal Products, By Type, 2016–2023 (USD Million)
Table 249 RoW: Implantable Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 250 RoW: Transmucosal Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 251 RoW: Transmucosal Drug Delivery Technology Market for Oral Formulations, By Type, 2016–2023 (USD Million)
Table 252 RoW: Transmucosal Drug Delivery Technology Market for Other Formulations, By Type, 2016–2023 (USD Million)
Table 253 RoW: Pulmonary Drug Delivery Technology Market, By Type, 2016–2023 (USD Million)
Table 254 RoW: Pulmonary Drug Delivery Technology Market for Nebulizers, By Type, 2016–2023 (USD Million)
Table 255 RoW: Drug Delivery Technology Market, By Application, 2016–2023 (USD Billion)
Table 256 RoW: Drug Delivery Technology Market, By Facility of Use, 2016–2023 (USD Billion)
Table 257 Drug Delivery Technology Market Player Ranking, 2017
Table 258 Product Launches and Approvals, 2016–2018
Table 259 Collaborations, Agreements, and Joint Ventures, 2016–2018
Table 260 Acquisitions, 2015–2018
Table 261 Expansions, 2015–2018
 
 
List of Figures (39 Figures)
 
Figure 1 Drug Delivery Technology Market Segmentation
Figure 2 Drug Delivery Technology Market: Research Methodology
Figure 3 Research Design
Figure 4 Figure 3: Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Drug Delivery Technology Market, By Route of Administration, 2018 Vs. 2023 (USD Billion)
Figure 9 Oral Drug Delivery Technology Market for Solid Drugs, By Dosage Form, 2018 Vs. 2023 (USD Billion)
Figure 10 Drug Delivery Technology Market, By Facility of Use, 2018 Vs. 2023 (USD Billion)
Figure 11 Drug Delivery Technology Market, By Application, 2018 Vs. 2023 (USD Billion)
Figure 12 Geographical Snapshot of the Drug Delivery Technology Market
Figure 13 Increasing Prevalence of Chronic Diseases is Driving the Growth of the Drug Delivery Technology Market
Figure 14 Topical Drug Delivery Segment to Register the Highest Growth Rate During the Forecast Period
Figure 15 Hospitals Accounted for the Largest Market Share in 2018
Figure 16 Infectious Diseases Application Segment Accounted for the Largest Share of the Market in 2018
Figure 17 China is Expected to Grow at the Highest Rate During the Forecast Period
Figure 18 Drug Delivery Technology Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Topical Drug Delivery to Witness Highest Growth During the Forecast Period
Figure 20 Home Care Settings to Witness the Highest Growth in the Drug Delivery Technology Market From 2018 to 2023
Figure 21 Infectious Diseases Segment Will Continue to Dominate the Drug Delivery Technology Market During the Forecast Period
Figure 22 North America: Drug Delivery Technology Market Snapshot
Figure 23 Europe: Drug Delivery Technology Market Snapshot
Figure 24 Asia Pacific: Drug Delivery Technology Market Snapshot
Figure 25 RoW: Drug Delivery Technology Market Snapshot
Figure 26 Key Developments in the Drug Delivery Technology Market From 2016 to 2019
Figure 27 MnM Dive-Vendor Comparison Matrix: Drug Delivery Technology Market
Figure 28 MnM Dive-Vendor Comparison Matrix for Start-Ups: Drug Delivery Technology Market
Figure 29 Johnson & Johnson: Company Snapshot (2017)
Figure 30 Novartis AG: Company Snapshot (2017)
Figure 31 F. Hoffmann-La Roche Ltd.: Company Snapshot (2017)
Figure 32 Pfizer, Inc.: Company Snapshot (2017)
Figure 33 Bayer AG: Company Snapshot (2017)
Figure 34 Antares Pharma, Inc.: Company Snapshot (2017)
Figure 35 Becton, Dickinson and Company: Company Snapshot (2017)
Figure 36 GlaxoSmithKline PLC: Company Snapshot (2017)
Figure 37 3M: Company Snapshot (2017)
Figure 38 Merck & Co., Inc.: Company Snapshot (2017)
Figure 39 Sanofi: Company Snapshot (2017)

This study involved four major activities to estimate the current size of the pharmaceutical drug delivery market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the pharmaceutical drug delivery market. Secondary sources such as the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), Health Canada, American Journal of Drug Delivery and Therapeutics, Center for Drug Delivery and Nanomedicine, Parenteral Drug Association (PDA), International Journal of Drug Delivery, Annual Reports, Press Releases, SEC Filings, and Investor Presentations were used. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the pharmaceutical drug delivery market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The pharmaceutical drug delivery market generated by leading players has been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global pharmaceutical drug delivery market on the basis of route of administration, application, facility of use, and region
  • To provide detailed information about the factors influencing market growth (drivers, restraints, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of market segments in North America, Europe, Asia Pacific, and the Rest of the World
  • To profile key players and comprehensively analyze their product portfolios, market rankings, and core competencies
  • To track and analyze competitive developments, such as acquisitions, collaboration, product approvals, expansions, and agreements in the global pharmaceutical drug delivery market

Scope of the report

Report Metric

Details

Market size available for years

2016–2023

Base year considered

2017

Forecast period

2018–2023

Forecast units

Value (USD)

Segments covered

Route of administration, applications, facility of use, and region

Geographies covered

North America, Asia Pacific, Europe, and the Rest of the World

Companies covered

Johnson & Johnson, Inc. (US), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (US), Bayer AG (Germany), Pfizer, Inc. (US), Novartis AG (Switzerland), 3M Company (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc, (UK), Sanofi (France), and Antares Pharma, Inc. (US)

This report categorizes the pharmaceutical drug delivery market into the following segments and subsegments:

Pharmaceutical Drug Delivery Market, by Route of Administration

  • Oral Drug Delivery
  • Pulmonary Drug Delivery
  • Injectable Drug Delivery
  • Ocular Drug Delivery
  • Nasal Drug Delivery
  • Topical Drug Delivery
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery

Pharmaceutical Drug Delivery Market, by Application

  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Central Nervous System Disorders
  • Autoimmune Diseases

Pharmaceutical Drug Delivery Market, by Facility of Use

  • Hospitals
  • Home Care Settings
  • ASC/Clinics
  • Diagnostic Centers

Pharmaceutical Drug Delivery Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • RoW

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.

The following customization options are available for this report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
MD 3871
Published ON
Mar, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Drug Delivery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home